Mirum Pharmaceuticals (MIRM) Short-term Investments (2019 - 2026)

Mirum Pharmaceuticals' Short-term Investments history runs 8 years deep, the most recent figure standing at $61.4 million for Q1 2026.

• In Q1 2026, Short-term Investments fell 6.83% year-over-year to $61.4 million; the TTM figure through Mar 2026 stood at $61.4 million (down 6.83% YoY), while the FY2025 annual figure was $86.6 million, up 49.87% from the prior year.
• Short-term Investments was $61.4 million for Q1 2026 at Mirum Pharmaceuticals, down from $86.6 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $149.6 million in Q3 2022 to a low of $3.0 million in Q3 2023.
• Historically, Short-term Investments has averaged $73.5 million across 5 years, with a median of $69.7 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Short-term Investments slumped 98.01% in 2023, then jumped 1969.2% in 2024.
• A 5-year view of Short-term Investments shows it stood at $123.7 million in 2022, then slumped by 97.6% to $3.0 million in 2023, then surged by 1845.88% to $57.8 million in 2024, then jumped by 49.87% to $86.6 million in 2025, then declined by 29.19% to $61.4 million in 2026.
• The last three Short-term Investments figures came in at $61.4 million (Q1 2026), $86.6 million (Q4 2025), and $93.5 million (Q3 2025), per Business Quant data.